Exagen Diagnostics announces purchase of Cypress Diagnostic Business; no terms disclosed
9:02 am ET 10/12/2010- Briefing.com
Exagen Diagnostics announces the purchase of Cypress Bioscience (CYPB) diagnostic business. No terms were disclosed. Exagen will purchase the diagnostic business in its entirety, including all testing services, intellectual property rights and equipment. Exagen has offered employment to all Cypress laboratory employees.
(Scov - In the words of Shakespeare? - J)
A mind troubled by doubt cannot focus on the course to victory.
Market Data 
Markets 
AI
